Dehydroabietic acid chemosensitizes drug-resistant acute lymphoblastic leukemia cells by downregulating survivin expression
Objective: To explore the mechanism of drug resistance in acute lymphoblastic leukemia and the anti-tumor effect of combination therapy of dehydroabietic acid and vincristine against acute lymphoblastic leukemia cells. Methods: Acute lymphoblastic leukemia cells REH and CCRF- CEM were employed to de...
Main Authors: | Li-Li Shen, Wei-Hua Huang, Hui-Jun Zhao, Xue-Wei Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Asian Pacific Journal of Tropical Biomedicine |
Subjects: | |
Online Access: | http://www.apjtb.org/article.asp?issn=2221-1691;year=2022;volume=12;issue=9;spage=383;epage=390;aulast=Shen |
Similar Items
-
Dehydroabietic Acid Is a Novel Survivin Inhibitor for Gastric Cancer
by: Won-Jin Kim, et al.
Published: (2021-05-01) -
Design of Lentiviral Vector of Apoptin and Investigating its Cytotoxic Effect on Reh Acute Lymphoblastic Leukemia Cells
by: A Anjam najmedini, et al.
Published: (2018-05-01) -
Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
by: Pei-Jie Shi, et al.
Published: (2016-02-01) -
Methanolic Extract from Aerial Parts of Artemisia Annua L. Induces Cytotoxicity and Enhances Vincristine-Induced Anticancer Effect in Pre-B Acute Lymphoblastic Leukemia Cells
by: Pargol Mashati, et al.
Published: (2019-07-01) -
Targeting survivin in leukemia
by: Bing Z. Carter, et al.
Published: (2011-12-01)